Literature DB >> 20338284

Trans fats in America: a review of their use, consumption, health implications, and regulation.

Valentina Remig1, Barry Franklin, Simeon Margolis, Georgia Kostas, Theresa Nece, James C Street.   

Abstract

Trans fatty acids have long been used in food manufacturing due in part to their melting point at room temperature between saturated and unsaturated fats. However, increasing epidemiologic and biochemical evidence suggest that excessive trans fats in the diet are a significant risk factor for cardiovascular events. A 2% absolute increase in energy intake from trans fat has been associated with a 23% increase in cardiovascular risk. Although Denmark has shown it is possible to all but eliminate commercial sources of trans fats from the diet, total elimination is not possible in a balanced diet due to their natural presence in dairy and meat products. Thus, the American Heart Association recommends limiting trans fats to <1% energy, and the American Dietetic Association, the Institute of Medicine, US Dietary Guidelines, and the National Cholesterol Education Project all recommend limiting dietary trans-fat intake from industrial sources as much as possible. The presence of small amounts of trans fat in hydrogenated or partially hydrogenated oils/food products will likely cause many Americans to exceed their recommended maximum. This likelihood is exacerbated by the Food and Drug Administration labeling rules, which allow products containing <0.5 g trans fat per serving to claim 0 g trans fat. Many products with almost 0.5 g trans fat, if consumed over the course of a day, may approximate or exceed the 2 g maximum as recommended by American Heart Association, all while claiming to be trans-fat free. Accordingly, greater transparency in labeling and/or active consumer education is needed to reduce the cardiovascular risks associated with trans fats. Copyright (c) 2010 American Dietetic Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20338284     DOI: 10.1016/j.jada.2009.12.024

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  34 in total

1.  Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.

Authors:  Theodore M Brasky; Cathee Till; Emily White; Marian L Neuhouser; Xiaoling Song; Phyllis Goodman; Ian M Thompson; Irena B King; Demetrius Albanes; Alan R Kristal
Journal:  Am J Epidemiol       Date:  2011-04-24       Impact factor: 4.897

2.  Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.

Authors:  Jamie E Mells; Ping P Fu; Pradeep Kumar; Tekla Smith; Saul J Karpen; Frank A Anania
Journal:  J Nutr Biochem       Date:  2014-12-06       Impact factor: 6.048

3.  Trans-Fatty Acid-Stimulated Mammary Gland Growth in Ovariectomized Mice is Fatty Acid Type and Isomer Specific.

Authors:  Grace E Berryhill; Susan G Miszewski; Josephine F Trott; Jana Kraft; Adam L Lock; Russell C Hovey
Journal:  Lipids       Date:  2017-01-10       Impact factor: 1.880

4.  Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet.

Authors:  Jamie E Mells; Ping P Fu; Shvetank Sharma; Darin Olson; Lihong Cheng; Jeffrey A Handy; Neeraj K Saxena; Dan Sorescu; Frank A Anania
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-28       Impact factor: 4.052

5.  Diet quality among US-born and foreign-born non-Hispanic blacks: NHANES 2003-2012 data.

Authors:  Alison G M Brown; Robert F Houser; Josiemer Mattei; Colin D Rehm; Dariush Mozaffarian; Alice H Lichtenstein; Sara C Folta
Journal:  Am J Clin Nutr       Date:  2018-05-01       Impact factor: 7.045

6.  Dietary fat types and 4-year cognitive change in community-dwelling older women.

Authors:  Olivia I Okereke; Bernard A Rosner; Dae H Kim; Jae H Kang; Nancy R Cook; JoAnn E Manson; Julie E Buring; Walter C Willett; Francine Grodstein
Journal:  Ann Neurol       Date:  2012-05-18       Impact factor: 10.422

7.  Fat discrimination: a phenotype with potential implications for studying fat intake behaviors and obesity.

Authors:  Lisa C H Liang; Johannah Sakimura; Daniel May; Cameron Breen; Elissa Driggin; Beverly J Tepper; Wendy K Chung; Kathleen L Keller
Journal:  Physiol Behav       Date:  2011-09-08

8.  Intake of trans fat and incidence of stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.

Authors:  James N Kiage; Peter D Merrill; Suzanne E Judd; Ka He; Loren Lipworth; Mary Cushman; Virginia J Howard; Edmond K Kabagambe
Journal:  Am J Clin Nutr       Date:  2014-02-12       Impact factor: 7.045

9.  Plasma concentrations of trans fatty acids in persons with type 2 diabetes between September 2002 and April 2004.

Authors:  Dawn C Schwenke; John P Foreyt; Edgar R Miller; Rebecca S Reeves; Mara Z Vitolins
Journal:  Am J Clin Nutr       Date:  2013-02-27       Impact factor: 7.045

Review 10.  The effectiveness of policies for reducing dietary trans fat: a systematic review of the evidence.

Authors:  Shauna M Downs; Anne Marie Thow; Stephen R Leeder
Journal:  Bull World Health Organ       Date:  2013-02-04       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.